Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
20,045,479
-
Share change
-
-1,231,490
-
Total reported value
-
$40,489,347
-
Put/Call ratio
-
86%
-
Price per share
-
$2.02
-
Number of holders
-
53
-
Value change
-
-$3,281,186
-
Number of buys
-
23
-
Number of sells
-
41
Institutional Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q2 2021
As of 30 Jun 2021,
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,045,479 shares.
The largest 10 holders included
BVF INC/IL, 5AM Venture Management, LLC, Omega Fund Management, LLC, VANGUARD GROUP INC, INTERWEST VENTURE MANAGEMENT CO, Stonepine Capital Management, LLC, ALETHEA CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, and JACOBS LEVY EQUITY MANAGEMENT, INC.
This page lists
53
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.